Clinical Trial Update: TRx0014 in Patients With Mild or Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update of TRx0014 in mild to moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TRx0014

Snippet

Sponsor: TauRx Therapeutics Ltd | Conditions: Dementia, Alzheimer Type | Phase 2 | Status: COMPLETED